Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion type Assertion NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_head.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion description "[PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion evidence source_evidence_literature NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion SIO_000772 7749407 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion wasDerivedFrom befree-20140225 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.
- NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_assertion wasGeneratedBy ECO_0000203 NP595832.RAGZbb0QPuCMyE686sMVqmr2L7xEUQd42yvqUlu17RsmA130_provenance.